Oxalisol 50 mg Injection (Oxaliplatin) is a prescription chemotherapy medicine used mainly in the treatment of colorectal cancer as part of combination regimens such as FOLFOX with fluorouracil and leucovorin or capecitabine. Oxaliplatin is a platinum‑containing anticancer agent that works by binding to DNA in cancer cells, interfering with their ability to replicate and leading to cell death. Oxalisol is administered by intravenous infusion under the supervision of trained healthcare professionals, with regular monitoring of blood counts and organ function to manage side effects.